Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerations

Osteoporosis is the most common metabolic bone disease. An imbalance in bone turnover lies at the root of its pathogenesis, i.e. a relatively higher bone resorption than bone formation rate, leading to bone mass loss and low-energy fractures [1]. Postmenopausal osteoporosis is the most common type of osteoporosis, characterized by an increasing incidence with aging [2]. Given the high life expectancy in Western countries, the number of postmenopausal women at risk of osteoporotic fractures is expected to rise in the next decades, thus compromising the quality of life of the affected women and further expanding the direct and indirect economic burden on healthcare systems [2].

Source: Maturitas - March 1, 2021 Category: Primary Care Authors: Stergios A. Polyzos, Athanasios D. Anastasilakis, Zoe A. Efstathiadou, Maria P. Yavropoulou, Polyzois Makras Source Type: research